These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33121498)

  • 1. A research agenda for non-communicable disease prevention and control in India.
    Kataria I; Siddiqui M; Gillespie T; Goodman M; Dhillon PK; Bann C; Squiers L
    Health Res Policy Syst; 2020 Oct; 18(1):126. PubMed ID: 33121498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of contextualisation in enhancing non-communicable disease programmes and policy implementation to achieve health for all.
    Liu H; Huffman MD; Trieu K
    Health Res Policy Syst; 2020 Apr; 18(1):38. PubMed ID: 32303249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health system challenges to hypertension and related non-communicable diseases prevention and treatment: perspectives from Ghanaian stakeholders.
    Laar AK; Adler AJ; Kotoh AM; Legido-Quigley H; Lange IL; Perel P; Lamptey P
    BMC Health Serv Res; 2019 Oct; 19(1):693. PubMed ID: 31615529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to, and facilitators of, the adoption of a sugar sweetened beverage tax to prevent non-communicable diseases in Namibia: a policy landscape analysis.
    Amukugo HJ; Abdool Karim S; Thow AM; Erzse A; Kruger P; Karera A; Hofman K
    Glob Health Action; 2021 Jan; 14(1):1903213. PubMed ID: 33876708
    [No Abstract]   [Full Text] [Related]  

  • 6. A health equity research agenda for India: results of a consultative exercise.
    Ravindran TKS; Seshadri T
    Health Res Policy Syst; 2018 Oct; 16(Suppl 1):94. PubMed ID: 30301455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and challenges in implementing adolescent and school health programmes in India: a rapid review.
    Jain N; Bahl D; Mehta R; Bassi S; Sharma K; Arora M
    BMJ Open; 2022 May; 12(5):e047435. PubMed ID: 35523489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-communicable disease (NCD) corners in public sector health facilities in Bangladesh: a qualitative study assessing challenges and opportunities for improving NCD services at the primary healthcare level.
    Rawal LB; Kanda K; Biswas T; Tanim MI; Poudel P; Renzaho AMN; Abdullah AS; Shariful Islam SM; Ahmed SM
    BMJ Open; 2019 Oct; 9(10):e029562. PubMed ID: 31594874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving access to medicines for non-communicable diseases in rural India: a mixed methods study protocol using quasi-experimental design.
    Prashanth NS; Elias MA; Pati MK; Aivalli P; Munegowda CM; Bhanuprakash S; Sadhana SM; Criel B; Bigdeli M; Devadasan N
    BMC Health Serv Res; 2016 Aug; 16(1):421. PubMed ID: 27549020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health research prioritization in Somalia: setting the agenda for context specific knowledge to advance universal health coverage.
    Ssendagire S; Mohamoud SA; Bashir F; Jamal MA; Bulale M; Azad A; Warsame MY; Hassan F; Omar M; Dalmar A; Karanja MJ; Nyagah LM; Warsame A; Diriye AA; Malik SMMR
    Front Public Health; 2023; 11():1202034. PubMed ID: 38026320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition related non-communicable diseases and sugar sweetened beverage policies: a landscape analysis in Zambia.
    Mukanu MM; Abdool Karim S; Hofman K; Erzse A; Thow AM
    Glob Health Action; 2021 Jan; 14(1):1872172. PubMed ID: 33876714
    [No Abstract]   [Full Text] [Related]  

  • 12. Priority setting for non-communicable disease prevention - Co-producing a regulatory agenda informing novel codes of practice in Australia.
    Heenan M; Jan S; Ralph M; Sacks G; Swinburn B; Shanthosh J
    Soc Sci Med; 2023 Sep; 333():116149. PubMed ID: 37573676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining a Research Agenda for Layperson Prehospital Hemorrhage Control: A Consensus Statement.
    Goralnick E; Ezeibe C; Chaudhary MA; McCarty J; Herrera-Escobar JP; Andriotti T; de Jager E; Ospina-Delgado D; Goolsby C; Hunt R; Weissman JS; Haider A; Jacobs L; ; Andrade E; Brown J; Bulger EM; Butler FK; Callaway D; Caterson EJ; Choudhry NK; Davis MR; Eastman A; Eastridge BJ; Epstein JL; Evans CL; Gausche-Hill M; Gestring ML; Goldberg SA; Hanfling D; Holcomb JB; Jonson CO; King DR; Kivlehan S; Kotwal RS; Krohmer JR; Levy-Carrick N; Levy M; Meléndez Lugo JJ; Mooney DP; Neal MD; Niskanen R; O'Neill P; Park H; Pons PT; Prytz E; Rasmussen TE; Remley MA; Riviello R; Salim A; Shackelfold S; Smith ER; Stewart RM; Swaroop M; Ward K; Uribe-Leitz T; Jarman MP; Ortega G
    JAMA Netw Open; 2020 Jul; 3(7):e209393. PubMed ID: 32663307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated.
    Umeh CA; Rockers PC; Laing RO; Wagh O; Wirtz VJ
    Public Health; 2020 Apr; 181():73-79. PubMed ID: 31958672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the effectiveness of implementation: the National Demonstration Areas for Comprehensive Prevention and Control of Non-communicable Diseases].
    Zhang J; Jin RR; Li JJ; Li JL; Su XW; Deng GJ; Ma S; Zhao J; Wang YP; Bian F; Qu YM; Shen ZZ; Jiang Y; Liu YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):394-400. PubMed ID: 29699025
    [No Abstract]   [Full Text] [Related]  

  • 16. Bangladesh policy on prevention and control of non-communicable diseases: a policy analysis.
    Biswas T; Pervin S; Tanim MIA; Niessen L; Islam A
    BMC Public Health; 2017 Jun; 17(1):582. PubMed ID: 28629430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reiterating the Importance of Publicly Funded and Provided Primary Healthcare for Non-communicable Diseases: The Case of India Comment on "Universal Health Coverage for Non-communicable Diseases and Health Equity: Lessons From Australian Primary Healthcare".
    Nandi S
    Int J Health Policy Manag; 2022 Jun; 11(6):847-850. PubMed ID: 34814664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan--Prelude and finale.
    Nishtar S
    J Pak Med Assoc; 2004 Dec; 54(12 Suppl 3):S1-8. PubMed ID: 15745321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PERSPECTIVES: Mental Health Policy in India: Seven Sets of Questions and Some Answers.
    Mirza A; Singh N
    J Ment Health Policy Econ; 2019 Mar; 22(1):25-37. PubMed ID: 30991353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.